Mark A McCoy

Title: Mark A McCoy: Innovator in Cancer Treatment

Introduction

Mark A McCoy is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer-related proteins. With a total of 2 patents to his name, McCoy's work focuses on innovative solutions for cancer treatment.

Latest Patents

McCoy's latest patents include "Substituted piperidines as HDM2 inhibitors." This invention provides a compound of Formula I, which is described in detail, or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Additionally, the patent discloses pharmaceutical compositions comprising these compounds and potential methods of treating cancer using them. Another significant patent is "Substituted piperidines that increase P53 activity and the uses thereof." This invention reveals novel compounds that act as inhibitors of the HDM2 protein, along with methods for preparing such compounds and pharmaceutical compositions that include them. These compounds are aimed at treating, preventing, or inhibiting diseases associated with the HDM2 protein or P53.

Career Highlights

Throughout his career, McCoy has worked with prominent companies in the pharmaceutical industry, including Merck GmbH and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of McCoy's notable coworkers include Yao Ma and Brian Robert Lahue. Their collaboration has likely played a role in advancing the research and development of the compounds he has patented.

Conclusion

Mark A McCoy is a distinguished inventor whose work in developing cancer treatment compounds has the potential to make a significant impact in the medical field. His innovative patents reflect his commitment to advancing healthcare solutions.